Testing & evidence
Verified independent evidence
- Evidence status
- Verified independent evidence
- Manufacturer statement
- Product page: “Batch-identifiable with supporting analytical documentation available where applicable.” COA library: “Review available SPX Labs batch-specific analytical documentation and independent third-party laboratory results.” Retatrutide batch page: “Independent Third-Party Analytical Results”; “Laboratory: Janoshik Analytical”; “Identity, Peptide Content & Purity.”
- Laboratory
- Janoshik Analytical
- Certification body
- Not recorded
- Batch
- SPX-RT20-001
- Batch-specific report
- Recorded
- Report date
- 2026-04-16
- Evidence checked
- 2026-09-21
- Purity (HPLC)
- 99.531%
- Chromatogram
- Not shown
- Identity / mass spectrometry
- Not shown
- Measured content
- Within 1% of label
- Lab verification
- No public verification
- Microbiology / endotoxin
- Not shown
A public SPX batch report exists for Retatrutide 20mg with independent third-party results. It shows 99.531{a48505b7a92a5d64fa947b6701e2877576ce853b374f7be6d82c62f5ee4ca6d5} purity and 21.99 mg content for batch SPX-RT20-001, but no separate chromatogram image or contaminant/microbiology panel was visible.
Dose & value
- Vial size
- 20 mg
- Vials per pack
- 1 (single vial)
- Pack price
- Out Of Stock (last in-stock price £50.00)
- Price per vial
- £50.00
- Price per mg
- £2.50
- Compared with other suppliers
- 33% below the median (8 suppliers, same peptide)
- Price last checked
- 21 Sep 2026